Hydralazine and nitrates alone or combined for the management of chronic heart failure: A systematic review
- 1 October 2015
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 196, 61-69
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Randomized, double-blind, placebo-controlled long-term study of isosorbide-5-mononitrate therapy in patients with left ventricular dysfunction after acute myocardial infarctionAmerican Heart Journal, 2003
- Sustained-Release Isosorbide-5-Mononitrate Supports Captopril Treatment of Heart Failure Due to Coronary Artery DiseaseClinical Drug Investigation, 1997
- Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart FailureNew England Journal of Medicine, 1986
- Neurohumoral consequences of vasodilator therapy with hydralazine and nifedipine in severe congestive heart failureAmerican Heart Journal, 1986
- Comparative effects of captopril and isosorbide dinitrate on pulmonary arteriolar resistance and right ventricular function in patients with severe left ventricular failure: Results of a randomized crossover studyAmerican Heart Journal, 1985
- Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure.Circulation, 1983
- Comparative analysis of the hemodynamic actions of captopril and sodium nitroprusside in severe chronic congestive heart failureAmerican Heart Journal, 1982
- Immediate effects of hydralazine-isosorbide dinitrate combination on exercise capacity and exercise hemodynamics in patients with left ventricular failure.Circulation, 1979
- Comparative hemodynamic effects of chewable isosorbide dinitrate and nitroglycerin in patients with congestive heart failure.Circulation, 1975
- Hemodynamic Effects of Orally Administered Isosorbide Dinitrate in Patients with Congestive Heart FailureCirculation, 1974